Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients.
Katariina HänninenOlli JääskeläinenSanna-Kaisa HerukkaMerja Soilu-HänninenPublished in: Brain and behavior (2020)
In this small cohort of clinically stable IFN-treated Finnish MS patients, sNfL levels were similarly low in patients supplemented with high-dose vitamin D or placebo. Subclinical disease activity in MRI was associated with higher sNfL levels.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- disease activity
- high dose
- multiple sclerosis
- mass spectrometry
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- immune response
- magnetic resonance
- dendritic cells
- patient reported outcomes
- clinical trial
- rheumatoid arthritis patients